Back to top
more

The Cooper Companies (COO)

(Delayed Data from NSDQ)

$92.69 USD

92.69
776,707

+0.08 (0.09%)

Updated Jul 30, 2024 04:00 PM ET

After-Market: $93.10 +0.41 (0.44%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 19% (203 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.

Cooper Companies (COO) Q4 Earnings Lag Estimates, Margins Up

by Zacks Equity Research

Cooper Companies' (COO) fiscal fourth-quarter results reflect solid segmental and geographical performances.

The Cooper Companies (COO) Q4 Earnings Lag Estimates

by Zacks Equity Research

The Cooper Companies (COO) delivered earnings and revenue surprises of -2.67% and 1.52%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?

Cooper Companies (COO) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal fourth-quarter results are likely to reflect segmental strength.

The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LH vs. COO: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

LH vs. COO: Which Stock Is the Better Value Option?

Cooper Companies' (COO) Buyout to Boost Women's Healthcare

by Zacks Equity Research

Cooper Companies' (COO) agrees to acquire Generate Life Sciences. It will be an important addition to the former's present offerings, while improving women's healthcare.

LH vs. COO: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

LH vs. COO: Which Stock Is the Better Value Option?

Here's Why You Should Retain Cooper Companies (COO) Stock Now

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from strength in its business segments.

XRAY vs. COO: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

XRAY vs. COO: Which Stock Is the Better Value Option?

HSIC or COO: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HSIC vs. COO: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Alcon, National Vision, The Cooper Companies and EyePoint Pharma

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Alcon, National Vision, The Cooper Companies and EyePoint Pharma

Riya Anand headshot

4 Stocks to Keep a Watch on Amid Growing Optical Care Demand

by Riya Anand

Stocks like Alcon (ALC), National Vision (EYE), The Cooper Companies (COO) and EyePoint Pharmaceuticals (EYPT) are gaining momentum amid rising optical care demand.

Cooper Companies (COO) Q3 Earnings & Revenues Beat Estimates

by Zacks Equity Research

Cooper Companies' (COO) fiscal third-quarter earnings reflect solid segmental performance.

The Cooper Companies (COO) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

The Cooper Companies (COO) delivered earnings and revenue surprises of 3.33% and 5.36%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?

Aditi Saraogi headshot

Why The Cooper Companies (COO) Might Surprise This Earnings Season

by Aditi Saraogi

The Cooper Companies (COO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength.

The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

The Cooper Companies (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Retain Cooper Companies (COO) Stock Now

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from strength in its business segments.

Cooper Companies (COO) Unit's MiSight Gets Approval in China

by Zacks Equity Research

CooperVision, a unit of Cooper Companies (COO), receives approval for MiSight 1 day contact lenses from China's National Medical Products Administration for use in China.

Here's Why You Should Retain Abiomed (ABMD) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.

Strength Seen in The Cooper Companies (COO): Can Its 7.8% Jump Turn into More Strength?

by Zacks Equity Research

The Cooper Companies (COO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

HSIC vs. COO: Which Stock Is the Better Value Option?

by Zacks Equity Research

HSIC vs. COO: Which Stock Is the Better Value Option?

Trina Mukherjee headshot

3 Stocks to Tap the Promising Dental Supplies Industry

by Trina Mukherjee

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

HSIC vs. COO: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

HSIC vs. COO: Which Stock Is the Better Value Option?